ConductScience.org, home

Paper40684451

Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis.

Liu L and 9 others. Ann Med, 2025. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis. Papers, record 40684451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40684451

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Development and performance of female breast cancer incidence risk prediction models: a systematic review and meta-analysis.
PubMed
Journal
Ann Med
PubMed
Year
2025
PubMed
Publication types
Journal Article, Systematic Review, Meta-Analysis
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
1.37, provisional
iCite
Revised in PubMed
2026-06-12
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu LLiyuan
2Zhou PPeng
3Hou LLijuan
4Kao CChunyu
5Zhang ZZiyu
6Wang DDi
7Yu LLixiang
8Wang FFeihttps://orcid.org/0000-0002-0124-8062
9Wang YYongjiu
10Yu ZZhiganghttps://orcid.org/0000-0002-3093-4491

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
Machine LearningMajor topic
Models, StatisticalMajor topic
Humans
Female
Incidence
Risk Assessment
Risk Factors
Early Detection of Cancer

Source PubMed

Download CSV of topics

References144

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125744293A comparison between different prediction models for invasive breast cancer occurrence in the French E3N cohort.Breast Cancer Res Treat2015https://conductscience.org/library/papers/25744293PubMed
234051827Development and external validation of a breast cancer absolute risk prediction model in Chinese population.Breast Cancer Res2021https://conductscience.org/library/papers/34051827PubMed
331846476Use of detailed family history data to improve risk prediction,with application to breast cancer screening.PLoS One2019https://conductscience.org/library/papers/31846476PubMed
431196488Performance of prediction models on survival outcomes of colorectal cancer with surgical resection: A systematic review and meta-analysis.Surg Oncol2019https://conductscience.org/library/papers/31196488PubMed
534002584Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030.Cancer Biol Med2021https://conductscience.org/library/papers/34002584PubMed
636426919An Assessment of the Predictive Performance of Current Machine Learning-Based Breast Cancer Risk Prediction Models: Systematic Review.JMIR Public Health Surveill2022https://conductscience.org/library/papers/36426919PubMed
716261410Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population.Breast Cancer Res Treat2005https://conductscience.org/library/papers/16261410PubMed
88145275Validation of the Gail et al. model for predicting individual breast cancer risk.J Natl Cancer Inst1994https://conductscience.org/library/papers/8145275PubMed
936017156Predicting Breast Cancer Leveraging Supervised Machine Learning Techniques.Comput Math Methods Med2022https://conductscience.org/library/papers/36017156PubMed
1023164155Assessing risk of breast cancer in an ethnically South-East Asia population (results of a multiple ethnic groups study).BMC Cancer2012https://conductscience.org/library/papers/23164155PubMed
1137956433Breast Cancer Screening and Prevention.Ann Intern Med2023https://conductscience.org/library/papers/37956433PubMed
1238762325Burden of disease scenarios for 204 countries and territories, 2022-2050: a forecasting analysis for the Global Burden of Disease Study 2021.Lancet2024https://conductscience.org/library/papers/38762325PubMed
1330596875PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies.Ann Intern Med2019https://conductscience.org/library/papers/30596875PubMed
1425624442Model for individualized prediction of breast cancer risk after a benign breast biopsy.J Clin Oncol2015https://conductscience.org/library/papers/25624442PubMed
1521562243Projecting individualized absolute invasive breast cancer risk in Asian and Pacific Islander American women.J Natl Cancer Inst2011https://conductscience.org/library/papers/21562243PubMed
162593165Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.J Natl Cancer Inst1989https://conductscience.org/library/papers/2593165PubMed
1730032705A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes.Stat Methods Med Res2019https://conductscience.org/library/papers/30032705PubMed
1832565540Machine learning-based lifetime breast cancer risk reclassification compared with the BOADICEA model: impact on screening recommendations.Br J Cancer2020https://conductscience.org/library/papers/32565540PubMed
1937310244Evaluation of an AI Model to Assess Future Breast Cancer Risk.Radiology2023https://conductscience.org/library/papers/37310244PubMed
2035008209Validation of Breast Cancer Risk Models by Race/Ethnicity, Family History and Molecular Subtypes.Cancers (Basel)2021https://conductscience.org/library/papers/35008209PubMed

See all 144 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
42589412Artificial Intelligence and Genomic Data Analysis: New Frontiers in Precision Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/42589412PubMed
42515685Differential Effects of 17β-Estradiol, Its Metabolites, and Cadmium on Cytotoxicity and Redox-Related Pathways in Doxorubicin-Sensitive and -Resistant Breast Cancer Cell Lines.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42515685PubMed
41228354Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women.Cancers (Basel)2025https://conductscience.org/library/papers/41228354PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40684451

GET https://conductscience.org/api/papers/v1/40684451/references?page=2